Related Experiment Video
Updated: Jun 26, 2026

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
Published on: February 14, 2014
IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis
Eugene Varfolomeev1, John W Blankenship, Sarah M Wayson
1Department of Protein Engineering, Genentech, Inc., South San Francisco, CA 94080, USA.
Abstract:
Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli. They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics. Herein, we demonstrate that small-molecule IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of auto-ubiquitination activity and rapid proteasomal degradation of c-IAPs. The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis. Additionally, the c-IAP proteins were found to function as regulators of NF-kappaB signaling. Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degradation of NIK, the central ser/thr kinase in the noncanonical NF-kappaB pathway.
Insights
Small-molecule antagonists targeting inhibitor of apoptosis (IAP) proteins induce cancer cell death by triggering auto-ubiquitination and degradation of c-IAPs. These IAP antagonists also impact TNF signaling and NF-kappaB pathway regulation.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Inhibitor of apoptosis (IAP) proteins are crucial regulators of cell death, often overexpressed in cancers.
- IAPs present attractive targets for novel cancer therapeutic strategies.
Purpose of the Study:
- To investigate the mechanism of action for small-molecule IAP antagonists.
- To elucidate the role of c-IAP proteins in cell death and signaling pathways.
Main Methods:
- Treatment of cells with small-molecule IAP antagonists.
- Analysis of protein ubiquitination and degradation via proteasomal pathways.
- Assessment of cell death induction, TNF signaling, and NF-kappaB pathway activity.
Main Results:
- Small-molecule IAP antagonists induce auto-ubiquitination and degradation of c-IAPs.
- IAP antagonists trigger TNF-dependent and protein biosynthesis-dependent cell death.
- c-IAP1 and c-IAP2 regulate NF-kappaB signaling by promoting NIK degradation.
Conclusions:
- Small-molecule IAP antagonists represent a promising therapeutic approach for cancer treatment.
- Targeting IAPs can induce cancer cell death and modulate critical signaling pathways like NF-kappaB.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy

